Filgrastim
Sold as Neupogen mu, Filgrastim teva, Neukast, Grastiva, Neupogen
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 3
- Registrations
- 9
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Amgen south africa (pty)ltdCertificate held by Amgen | Neupogen mu, Neupogen | 30, 30 MU / ml, 30 MU / 0.5ml, 48, 48 / 0.5ml | 320032, 320033, Z0190 | S4 | PIPIL |
| Teva Pharmaceuticals (Pty) Ltd | Filgrastim teva | 30, 48 | 460317, 460318 | S4 | PIPIL |
| Accord Healthcare (Pty) Ltd | Neukast, Grastiva | 300, 480 | 481112, 481113, 481114, 481115 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Neupogen 30 mu EACH 0,5 ml PRE-FILLED SYRINGE CONTAINS FILGRASTIM 0,3 mg | 30 | 32003232/30.4/0032 | Registered | S4 | None |
| Neupogen 48 mu EACH 0,5 ml PRE-FILLED SYRINGE CONTAINS FILGRASTIM 0,48 mg | 48 | 32003332/30.4/0033 | Registered | S4 | None |
| Filgrastim teva 30 EACH PRE-FILLED SYRINGE CONTAINS : FILGRASTIM 30 MIU | 30Solution for injection or infusion | 46031746/32.16/0317Approved 23 November 2017 | Registered | S4 | PIPIL |
| Filgrastim teva 48 EACH PRE-FILLED SYRINGE CONTAINS : FILGRASTIM 48,0 MIU | 48Solution for injection or infusion | 46031846/32.16/0318Approved 23 November 2017 | Registered | S4 | PIPIL |
| Neukast 300 EACH PREIFILLED SYRINGE CONTAINS :FILGRASTIM 300,0 ug | 300 | 48111248/30.4/1112 | Registered | S4 | None |
| Neukast 480 EACH PREIFILLED SYRINGE CONTAINS :FILGRASTIM 480,0 ug | 480 | 48111348/30.4/1113 | Registered | S4 | None |
| Grastiva 300 EACH PREIFILLED SYRINGE CONTAINS :FILGRASTIM 300,0 ug | 300 | 48111448/30.4/1114 | Registered | S4 | None |
| Grastiva 480 EACH PREIFILLED SYRINGE CONTAINS :FILGRASTIM 480,0 ug | 480 | 48111548/30.4/1115 | Registered | S4 | None |
| Neupogen EACH VIAL CONATAINS FILGRASTIM 30 MILLION UNITS | 30 MU / ml. 30 MU / 0.5ml. 48 / 0.5mlInjection | Z0190Z/30.4/190Approved 14 September 2012 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Filgrastim
S4: Filgrastim
Consolidated Schedules 06 July 2026, line 6334
Pharmacological class: Probiotics. (class 30.4)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Filgrastim teva 30, Teva Pharmaceuticals (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.